about
Detection of human and rodent 5-HT3B receptor subunits by anti-peptide polyclonal antibodiesFrom mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics(+/-)-Nantenine analogs as antagonists at human 5-HT(2A) receptors: C1 and flexible congenersStatistical distribution of blood serotonin as a predictor of early autistic brain abnormalities.Pharmacology of serotonin and female sexual behaviorA placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophreniaDual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugsDifferential distribution of serotonin receptor subtypes in BNST(ALG) neurons: modulation by unpredictable shock stressGenetic variation in cortico-amygdala serotonin function and risk for stress-related disease5-HT radioligands for human brain imaging with PET and SPECTPharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.Review article: intestinal serotonin signalling in irritable bowel syndrome.Therapeutics of 5-HT3 receptor antagonists: current uses and future directions.Agonist- and antagonist-induced up-regulation of surface 5-HT3 A receptors.Ion channels and signaling in the pituitary gland.Efficacy of Risperidone Augmentation with Ondansetron in the Treatment of Negative and Depressive Symptoms in Schizophrenia: A Randomized Clinical Trial.The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target?Building a 5-HT3A Receptor Expression Map in the Mouse BrainHigh affinity binding of epibatidine to serotonin type 3 receptors5-HT3 receptor antagonists ameliorate fatigue: so much potential, so little knowledge!Serotonin-type 3 receptors mediate intestinal Polycose- and glucose-induced suppression of intake.Long-lasting bradypnea induced by repeated social defeat.Cryo-EM structure of 5-HT3A receptor in its resting conformation.The novel α7 nicotinic acetylcholine receptor agonist EVP-6124 enhances dopamine, acetylcholine, and glutamate efflux in rat cortex and nucleus accumbens.
P2860
Q24311662-E69A6A2B-AA2E-47A3-AC72-A352AB3D8C48Q24648063-65FF646C-31C9-4A39-9F39-82191FAE87DCQ24649697-BFAD9388-CD6E-48F5-8C4C-80C0735CE209Q24811773-5CC33E43-22F2-462C-86F3-B3756AE17AE0Q26861672-162ED7A5-BF99-4C47-983F-C4CA9ACE46E3Q28287576-47085E5A-3992-4B54-9E34-0A5379A80135Q28305100-B39E8918-013F-4A00-8481-6BD1C749C2AAQ30446175-D44E4E8D-3B85-4801-B6BF-8D0C9C983755Q30487278-129F9AE6-6CA7-4C4A-92C4-DB50856DF443Q34192729-F8CEE5CA-9AB4-430F-B4C7-6957217618F9Q34274859-2C3E55E2-3C22-43E9-A0A1-37B5B8F9B919Q34566461-B64322BE-40D9-4B53-88A9-0E7C507BD2DBQ35011413-96DE47F8-1D9F-4708-BB72-C96548632CE8Q35978097-4890CB48-BF2F-4074-AB75-ABE72839A1FCQ36003349-5270FB9B-D0BE-479B-9A08-820873123EB2Q37681434-52866BE1-85AD-49B6-92C8-749D5C62A70FQ37685759-BD302216-5BFD-466A-80EE-646D8373EB98Q37690392-0C2E144F-C539-4B92-8455-BE13C8E8C96EQ39646714-7A2629B4-7558-473B-BABE-90F7B7C0619BQ43003949-DD3AAA2C-C7F2-47CA-BA55-A8641E21DD90Q45271826-77EBF574-164B-4DBD-9502-56276A30E824Q47426638-A663A754-1E4D-4C09-B1E7-12AF2410BDAFQ48096048-DDF0A5A5-23FD-4AA3-BA36-DB01823722B2Q48785714-98B43CB6-B71D-4B28-8F8A-7993C8AA7D82
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
5-HT3 receptors.
@ast
5-HT3 receptors.
@en
type
label
5-HT3 receptors.
@ast
5-HT3 receptors.
@en
prefLabel
5-HT3 receptors.
@ast
5-HT3 receptors.
@en
P356
P1476
5-HT3 receptors.
@en
P2093
Brenda Costall
Robert J Naylor
P356
10.2174/1568007043482624
P577
2004-02-01T00:00:00Z